Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%
The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…
131,050€
0,77%
Echtzeit-Aktienkurs Neurocrine Biosciences Inc.
Bid:
Ask:
Nachrichten zur Neurocrine Biosciences Inc. Aktie
Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
Tokyo, Japan and Cambridge, UK, 9 May 2024 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) notes that its…
Neurocrine Biosciences, Inc. (NBIX) Q1 2024 Earnings Call Transcript
…
Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Sentia Medical Sciences Inc. today announced that they have further…
Neurocrine Biosciences executive sells $725k in stock By Investing.com
Neurocrine Biosciences executive sells $725k in stock…
Neurocrine Biosciences exec sells over $10m in company stock By Investing.com
Neurocrine Biosciences exec sells over $10m in company stock…
Neurocrine Biosciences exec sells shares worth over $420k By Investing.com
Neurocrine Biosciences exec sells shares worth over $420k…